Top Markets
#1 Islamic Coin Islamic Coin +155.98%
#2 Siren Siren +37.35%
#3 Venom Venom +21.93%
#4 Arowana Arowana +21.86%
#5 RedStone RedStone +15.45%
#6 Verus Coin Verus Coin +15.11%
#7 Perle Perle +13.58%
#8 KUB Coin KUB Coin +12.98%
#9 OpenEden OpenEden +11.97%
#10 Janction Janction +10.89%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Rank in Stocks #32153
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Share Price
$0.05504527
Last synced: 2026-08-17
Market Cap
$10.89M
Change (1 day)
15.38%
Change (1 year)
-10.64%
Country
CA
Trade Hemostemix Inc. (HEM)

Category

Healthcare
P/B ratio for Hemostemix Inc. (HEM)
P/B ratio as of 2026 TTM: 0
According to Hemostemix Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Hemostemix Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR